Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy.

Ponomarenko, Dmitry M; Gabai, Vladimir L; Sufianov, Albert A; Kolesnikov, Sergey I; Shneider, Alexander M.

Afiliação

Ponomarenko DM; Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation.
Gabai VL; CureLab Oncology, Inc, Dedham, MA, USA.
Sufianov AA; Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA.
Kolesnikov SI; Federal Center of Neurosurgery, Tyumen, Russian Federation.
Shneider AM; Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Oncotarget ; 11(3): 294-299, 2020 Jan 21.

Article em En | MEDLINE | ID: mdl-32076489